AstraZeneca

238 results

Nestle, the world’s top food and drinks maker, soared to all-time highs after giving an upbeat outlook for the year ahead on an improving outlook in China and North America.

European shares gave up three-month highs on Thursday after a surprise sharp decline in US retail sales pulled stocks lower in afternoon trading, spoi(...)

Malin’s investee company Poseida Therapeutics has filed for a potential IPO.

Life sciences investment company Malin said on Monday that its investee company Poseida Therapeutics has filed for a potential initial public offering(...)

US stocks looked to pare declines after a shaky start. Photograph: Bloomberg

European shares lost further ground in their first trading day of 2019 on Wednesday as fears about global growth, trade wars and political instability(...)

Applegreen jumped 9.49 per cent to €6 as stock moves across the Irish market were driven by thin trading volumes

Ireland’s stock market benchmark, the Iseq, joined a raft of European indices in a rally yesterday to end a volatile shortened week of trading that h(...)

Photograph: iStock

European shares edged up on Friday, buoyed by a bounce on Wall Street as a turbulent week drew to a close and investors licked their wounds. The Sto(...)

The main corporate news came courtesy of French construction group Vinci, which agreed to acquire control of Gatwick Airport for £2.9 billion (€3.2 billion), seizing its chance to add a major London hub to its aviation portfolio

The Euro Stoxx 50 index sank 1.2 per cent on Thursday, entering a bear market, as European equities failed to sustain optimism from the Wednesday rall(...)

Tesaro brings to GSK a marketed product for ovarian cancer, Zejula, which belongs to a promising new class of medicines.  Photograph: Toby Melville/Reuters

GlaxoSmithKline has agreed to buy US cancer specialist Tesaro for $5.1 billion (€4.5 billion), marking a major biotech investment by chief executive E(...)

Dr Elaine Sullivan, co-founder and chief executive of early-stage life-sciences company Carrick Therapeutics, has been chosen as The Irish Times Busin(...)

The Swiss-Irish bakery group Aryzta slumped 18 per cent to €1.23 on its secondary Dublin listing. Photograph: Arnd Wiegmann/Reuters

European shares made only modest gains on Thursday as a global rally that followed the US midterm elections faded, although strong results from a numb(...)

 AstraZeneca’s wave of new medicines include Imfinzi and Tagrisso for lung cancer, Lynparza for ovarian cancer and Fasenra for severe asthma. Photograph: Stefan Wermuth//Reuters

Strong demand for AstraZeneca’s new drugs – especially those for cancer – drove a return to sales growth in the third quarter and the drugmaker said i(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »